Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | — | 10M |
| Cost of revenue | — | 3M |
| Gross profit | — | 6M |
| Research and development | — | 42,000 |
| Selling, general and administrative | 8M | 7M |
| Operating expenses | 8M | 7M |
| Operating income | −8M | −7M |
| Net income | −22M | −7M |
| Earnings per share | −3.80 | −12.68 |
| Weighted average shares | 6M | 679,000 |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 18M | 8M | 2M | 5M | 8M | 430,000 | 776,000 | 751,000 |
| Receivables | — | — | — | — | — | — | 704,000 | 547,000 |
| Inventory | — | — | — | 467,000 | — | 0 | 473,000 | 700,000 |
| Current assets | 19M | 9M | 3M | 6M | 9M | 2M | 2M | 2M |
| Property, plant and equipment | — | — | 6,000 | 11,000 | 12,000 | 44,000 | 61,000 | 44,000 |
| Total assets | 180M | 9M | 3M | 7M | 10M | 3M | 4M | 4M |
| Current liabilities | 4M | 1M | 1M | 2M | 3M | 3M | 2M | 4M |
| Total liabilities | 41M | 32M | 2M | 3M | 4M | 4M | 3M | 5M |
| Equity | 139M | −23M | 1M | 4M | 6M | −129,000 | 1M | −617,000 |
| Shares outstanding | 27M | 25M | 6M | 6M | 6M | 977,000 | 5M | 1M |
| Shares issued | 27M | 25M | 6M | 6M | 6M | 977,000 | 5M | 1M |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | −8M | −7M |
| Depreciation and amortisation | — | 40,000 |
| Capital expenditure | — | 6,000 |
| Investing cash flow | — | 1M |
| Dividends paid | 5M | 0 |
| Financing cash flow | 5M | 1M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator